Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NKTRNKTR
5 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in Nektar Therapeutics

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 284,971 shares of NKTR (Nektar Therapeutics), worth $19.9M as of 2026-Q2. The position was increased (+69.6% shares). NKTR represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$19.9M

Current Shares

284,971

Total Value Change

+$18.2M

Total Shares Change

+219,042

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
284,971
+69.6%
$19.9M0.0%$69.81
42
2026-Q1
Increased
168,007
+39.6%
$12.1M0.0%$68.11
37
2025-Q4
Increased
120,380
+5.0%
$5.1M0.0%$41.90
28
2025-Q3
Increased
114,664
+73.9%
$6.5M0.0%$58.92
41
2025-Q2
New
65,929
-
$1.7M0.0%$25.76
36

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used